Valuation: Terumo Corporation

Market Cap 3,428B 21.17B 18.53B 17.08B 15.83B 30.05B 2,010B 30.53B 205B 79.63B 992B 79.5B 77.77B P/E 2027 *
20.5x
P/E 2028 * 18.5x
Enterprise Value 3,504B 21.64B 18.94B 17.45B 16.18B 30.71B 2,054B 31.21B 209B 81.39B 1,014B 81.25B 79.49B EV / Sales 2027 *
2.83x
EV / Sales 2028 * 2.62x
Free-Float
97.07%
Yield 2027 *
1.53%
Yield 2028 * 1.71%
1 day-2.04%
1 week+1.90%
Current month+1.90%
1 month-0.35%
3 months+2.31%
6 months+0.20%
Current year+0.29%
1 week 2,152
Extreme 2152
2,364.5
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%+1.90%-7.08%+5.37% 21.17B
+0.09%+3.62%-28.38%-10.75% 167B
-1.71%+4.19%-6.84%-4.55% 107B
+0.96%+6.80%+3.36%+59.75% 59.24B
-6.77%-7.86%+44.51%+46.55% 52.99B
-2.21%+0.04%-12.41%-40.61% 43.07B
-4.64%-1.89% - - 36.37B
+0.13%+6.68%-12.30%-43.76% 28.39B
-1.52%-3.63%+59.53%-6.78% 25.16B
-2.10%-0.49%-9.16%-5.28% 20.99B
Average -1.90%+4.63%+3.47%-0.01% 56.16B
Weighted average by Cap. -1.43%+5.14%-5.03%+1.08%

Financials

2027 *2028 *
Net sales 1,236B 7.64B 6.68B 6.16B 5.71B 10.84B 725B 11.01B 73.86B 28.72B 358B 28.67B 28.05B 1,315B 8.12B 7.11B 6.55B 6.07B 11.53B 771B 11.71B 78.56B 30.55B 380B 30.5B 29.84B
Net income 166B 1.02B 895M 825M 764M 1.45B 97.03B 1.47B 9.89B 3.84B 47.89B 3.84B 3.76B 185B 1.14B 1B 923M 855M 1.62B 109B 1.65B 11.06B 4.3B 53.58B 4.29B 4.2B
Net Debt 75.69B 468M 409M 377M 349M 663M 44.37B 674M 4.52B 1.76B 21.9B 1.76B 1.72B 14.29B 88.27M 77.24M 71.19M 65.98M 125M 8.38B 127M 854M 332M 4.13B 331M 324M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
08/07/26 ¥2,276.50 -2.04% 5,188,900
07/07/26 ¥2,324.00 +1.33% 4,707,100
06/07/26 ¥2,293.50 +1.57% 2,726,200
03/07/26 ¥2,258.00 +1.96% 5,994,400
02/07/26 ¥2,214.50 +2.69% 5,058,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,324.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+27.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock